According to IMARC Group, the global molecular cytogenetics market is expected to continue its strong growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/molecular-cytogenetics-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
According to IMARC Group, the global Blood Culture Test market is expected to experience strong growth during the forecast period (2020-2025).
To learn more about this market, visit us at: https://www.imarcgroup.com/blood-culture-test-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests.
For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Biopsy devices market Research, Industry Trends, Strategies, Growth, Regional...IMARC Group
According to IMARC Group, the global biopsy devices is market to grow at a CAGR of around 5% during 2020-2025.
To learn more about this market, visit us at: https://www.imarcgroup.com/biopsy-devices-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies.
For more information, request for a free sample report here: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
According to the latest report by IMARC Group,the global gene expression analysis marketexhibited strong growth during 2015-2020.
Gene expression analysis is extensively used across clinical, research and pharmaceutical settings to study individual genes, gene pathways or greater gene activity profiles.
Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...IMARC Group
According to the latest report by IMARC Group,the global flow cytometry market size reached US$ 4.3 Billion in 2020.
Flow cytometry is a laser-based technology that analyses the physical and chemical characteristics of cells or particles. This technology enables researchers to simultaneously conduct a multi-paramedic analysis of a group of cells.
Automatic Identification and Data Capture Market Report 2020: Strategic Indus...IMARC Group
The global automatic identification and data capture (AIDC) market grew at a CAGR of around 11% during 2014-2019. Looking forward, IMARC Group expects the global automatic identification and data capture market to continue its strong growth during 2020-2025.
To learn more about this market, visit us at: https://www.imarcgroup.com/automatic-identification-data-capture-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global automatic identification and data capture market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on offering, product type, vertical and region. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/automatic-identification-data-capture-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Blood culture test market Research, Industry Trends, Strategies, Growth, Regi...IMARC Group
According to IMARC Group, the global Blood Culture Test market is expected to experience strong growth during the forecast period (2020-2025).
To learn more about this market, visit us at: https://www.imarcgroup.com/blood-culture-test-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A rise in the incidences of bloodstream infections (BSI), sepsis, and environment borne diseases around the world have majorly contributed to the growth of the market. Apart from this, the increasing cases of bacterial infections like tuberculosis (TB) in developing and underdeveloped countries are fueling the demand for bacterial culture tests.
For more information, request for a free sample report here: https://www.imarcgroup.com/blood-culture-test-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Biopsy devices market Research, Industry Trends, Strategies, Growth, Regional...IMARC Group
According to IMARC Group, the global biopsy devices is market to grow at a CAGR of around 5% during 2020-2025.
To learn more about this market, visit us at: https://www.imarcgroup.com/biopsy-devices-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies.
For more information, request for a free sample report here: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
According to the latest report by IMARC Group,the global gene expression analysis marketexhibited strong growth during 2015-2020.
Gene expression analysis is extensively used across clinical, research and pharmaceutical settings to study individual genes, gene pathways or greater gene activity profiles.
Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.
Flow cytometry Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends b...IMARC Group
According to the latest report by IMARC Group,the global flow cytometry market size reached US$ 4.3 Billion in 2020.
Flow cytometry is a laser-based technology that analyses the physical and chemical characteristics of cells or particles. This technology enables researchers to simultaneously conduct a multi-paramedic analysis of a group of cells.
Automatic Identification and Data Capture Market Report 2020: Strategic Indus...IMARC Group
The global automatic identification and data capture (AIDC) market grew at a CAGR of around 11% during 2014-2019. Looking forward, IMARC Group expects the global automatic identification and data capture market to continue its strong growth during 2020-2025.
To learn more about this market, visit us at: https://www.imarcgroup.com/automatic-identification-data-capture-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global automatic identification and data capture market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on offering, product type, vertical and region. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/automatic-identification-data-capture-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Global artificial intelligenceGlobal Artificial Intelligence (AI) for Drug Di...GMI Research
Global AI for Drug Discovery Market by Drug Type (Small Molecule and Large Molecules), By Technology (Deep Learning and machine learning), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases and Others) End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025
The global market for ablation technologies is expected to grow from $ 3,653.1 million in 2021 to $ 5,724.6 million in 2026. The market is expected to grow at a CAGR of 9.4% over the forecast period (2021-2026). Some of the market's key participants are Abbott, AngioDynamics, AtriCure, BTG, Boston Scientific, CONMED, Dornier MedTech, EDAP TMS, Hologic, IRIDEX, Johnson & Johnson, Lumenis, Medtronic, Merit Medical, Olympus, Smith & Nephew. This report intends to identify significant growth areas and to explore relevant market strategies. This in-depth analysis delves into the global market for ablation technologies. The primary goal of this research is to examine the potential growth areas, significant trends, and the market's impact on the industry. The report also reviews the adoption of ablation technologies in both established and emerging markets.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade.
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
United States IVD Market (By Application Segments, Products, Region, End User...iGATE RESEARCH
iGATE Research has released a research report on “United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=166
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Molecular Diagnostics Industry Analysis Report, 2016 To 2024Signitech
Projected to grow at a CAGR of almost 9% from 2016 to 2024, the molecular diagnostics market is expected to witness significant growth over the forecast period owing to rapid surge of infectious diseases.
Molecular Diagnostics Market Research Report, 2024Hexa Research
The molecular diagnostics market was valued at over USD 6.40 billion in 2015. It is likely to grow at a CAGR of around 9% during the forecast period (2016-2024).
The global Peripheral Vascular Devices market is segregated on the basis of Product as EVAR Stent Grafts, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, and Other Devices.
What are the liquid biopsy fundamentals? What are the goals of liquid biopsy? What are the market trends in liquid biopsy? Who's investing in liquid biopsy? What biomarkers are driving liquid biopsy?
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...IMARC Group
The global orphan drugs market exhibited moderate growth during 2014-2019. Looking forward, IMARC Group expects the global orphan drugs market to exhibit moderate growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/orphan-drugs-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global orphan drugs market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Companion Diagnostics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...IMARC Group
The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027.
More Info:- https://www.imarcgroup.com/companion-diagnostics-market
Global artificial intelligenceGlobal Artificial Intelligence (AI) for Drug Di...GMI Research
Global AI for Drug Discovery Market by Drug Type (Small Molecule and Large Molecules), By Technology (Deep Learning and machine learning), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases and Others) End-Users (Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025
The global market for ablation technologies is expected to grow from $ 3,653.1 million in 2021 to $ 5,724.6 million in 2026. The market is expected to grow at a CAGR of 9.4% over the forecast period (2021-2026). Some of the market's key participants are Abbott, AngioDynamics, AtriCure, BTG, Boston Scientific, CONMED, Dornier MedTech, EDAP TMS, Hologic, IRIDEX, Johnson & Johnson, Lumenis, Medtronic, Merit Medical, Olympus, Smith & Nephew. This report intends to identify significant growth areas and to explore relevant market strategies. This in-depth analysis delves into the global market for ablation technologies. The primary goal of this research is to examine the potential growth areas, significant trends, and the market's impact on the industry. The report also reviews the adoption of ablation technologies in both established and emerging markets.
Gynecological Devices Market Size, Share and Trend Analysis ReportSignitech
The global gynecological devices market size was valued at USD 8.9 billion in 2018. It is anticipated to exhibit a CAGR of 8.4% during the forecast period.
There will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade.
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
United States IVD Market (By Application Segments, Products, Region, End User...iGATE RESEARCH
iGATE Research has released a research report on “United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=166
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Molecular Diagnostics Industry Analysis Report, 2016 To 2024Signitech
Projected to grow at a CAGR of almost 9% from 2016 to 2024, the molecular diagnostics market is expected to witness significant growth over the forecast period owing to rapid surge of infectious diseases.
Molecular Diagnostics Market Research Report, 2024Hexa Research
The molecular diagnostics market was valued at over USD 6.40 billion in 2015. It is likely to grow at a CAGR of around 9% during the forecast period (2016-2024).
The global Peripheral Vascular Devices market is segregated on the basis of Product as EVAR Stent Grafts, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, and Other Devices.
What are the liquid biopsy fundamentals? What are the goals of liquid biopsy? What are the market trends in liquid biopsy? Who's investing in liquid biopsy? What biomarkers are driving liquid biopsy?
Orphan drugs market Report with Leading Competitor Analysis, Strategies and F...IMARC Group
The global orphan drugs market exhibited moderate growth during 2014-2019. Looking forward, IMARC Group expects the global orphan drugs market to exhibit moderate growth during the next five years.
To learn more about this market, visit us at: https://www.imarcgroup.com/orphan-drugs-market
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The report provides an analysis of the key trends in each sub-segment of the global orphan drugs market report, along with forecasts for growth at the global, regional and country level from 2020-2025. The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players.
For more information, request for a free sample report here: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Companion Diagnostics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...IMARC Group
The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027.
More Info:- https://www.imarcgroup.com/companion-diagnostics-market
Europe DNA Sequencing Products Market by Product Type, Distribution Channel, ...IMARC Group
The Europe DNA sequencing products market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028.
More Info:- https://www.imarcgroup.com/europe-dna-sequencing-products-market
Pharmacovigilance Market PPT 2022: Size, Growth, Demand and Forecast till 2027IMARC Group
The global pharmacovigilance market size reached US$ 6.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2027, exhibiting a CAGR of 10.5% during 2022-2027.
More Info:- https://www.imarcgroup.com/pharmacovigilance-market
Monoclonal Antibodies Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...IMARC Group
The global monoclonal antibodies market size reached US$ 207.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 307.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.
More Info:- https://www.imarcgroup.com/monoclonal-antibodies-market
Cell-Based Assay Market 2022-2027: Size, Share, Trends, Analysis & Research ...IMARC Group
According to the latest report by IMARC Group, that the global cell-based assay market size reached US$ 18.9 Billion in 2021. Cell-based assay or cellular assay is an analytical method to determine the concentration of a substance by observing its effects on living organisms (in vivo) or tissues (in vitro). It provides a closer representation of the real-life model, which helps to verify the biological activity of drugs and determine whether the antibodies produced by the patient are neutralizing the drug.
Blood Culture Test Market Growth, Demand and Challenges of the Key Industry P...IMARC Group
The global blood culture test market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/blood-culture-test-market
Image-guided Therapy Systems Market Growth, Demand and Challenges of the Key ...IMARC Group
The global image-guided therapy systems market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.
More Info:- https://www.imarcgroup.com/image-guided-therapy-systems-market
Cancer Biomarkers Market by Product Type, Distribution Channel, End User 2024...IMARC Group
The global cancer biomarkers market size reached US$ 27.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 77.0 Billion by 2032, exhibiting a growth rate (CAGR) of 11.7% during 2024-2032.
More Info:- https://www.imarcgroup.com/cancer-biomarkers-market
Recombinant DNA Technology Market by Product Type, Distribution Channel, End ...IMARC Group
The global recombinant DNA technology market size reached US$ 729.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 966.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.
More Info:- https://www.imarcgroup.com/recombinant-dna-technology-market
DNA Methylation Market Growth, Demand and Challenges of the Key Industry Play...IMARC Group
The global DNA methylation market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/dna-methylation-market
Cancer Tumor Profiling Market Growth, Demand and Challenges of the Key Indust...IMARC Group
The global cancer tumor profiling market reached a value of US$ 9.38 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 18.22 Billion by 2027 exhibiting a growth rate (CAGR) of 11.20% during 2022-2027.
More Info:- https://www.imarcgroup.com/cancer-tumor-profiling-market
Medical Simulation Market Share, Size, Growth, Opportunity and Forecast 2022-...IMARC Group
The global medical simulation market size reached US$ 1.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2027, exhibiting a growth rate (CAGR) of 13.62% during 2022-2027.
Read More: https://www.imarcgroup.com/medical-simulation-market
DNA Sequencing Products Market by Product Type, Distribution Channel, End Use...IMARC Group
The global DNA sequencing products market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.76% during 2023-2028.
More Info:- https://www.imarcgroup.com/dna-sequencing-products-market
Telemedicine Market by Product Type, Distribution Channel, End User 2023-2028IMARC Group
The global telemedicine market size reached US$ 59.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 218.0 Billion by 2028, exhibiting a growth rate (CAGR) of 21.9% during 2023-2028.
More Info:- https://www.imarcgroup.com/telemedicine-market
Telemedicine Market Growth, Demand and Challenges of the Key Industry Players...IMARC Group
The global telemedicine market size reached US$ 74.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 465.3 Billion by 2032, exhibiting a growth rate (CAGR) of 22.9% during 2024-2032.
More Info:- https://www.imarcgroup.com/telemedicine-market
Glaucoma Therapeutics Market Growth, Demand and Challenges of the Key Industr...IMARC Group
The global glaucoma therapeutics market size reached US$ 7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2027, exhibiting a growth rate (CAGR) of 6.52% during 2022-2027.
More Info:- https://www.imarcgroup.com/glaucoma-therapeutics-market
Computed Tomography Market by Product Type, Distribution Channel, End User 20...IMARC Group
The global computed tomography market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.27% during 2024-2032.
More Info:- https://www.imarcgroup.com/computed-tomography-market
Nanopore Technologies Market PPT: Demand, Trends and Business Opportunities 2...IMARC Group
The global nanopore technologies market size reached US$ 244.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 511.5 Million by 2028, exhibiting a growth rate (CAGR) of 12.4% during 2023-2028.
More Info:- https://www.imarcgroup.com/nanopore-technologies-market
Protein Detection & Quantification Market PPT: Demand, Trends and Business Op...IMARC Group
The global protein detection & quantification market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.2% during 2023-2028.
More Info:- https://www.imarcgroup.com/protein-detection-quantification-market
Similar to Molecular cytogenetics market Report, Industry Analysis, Share, Size and Forecast Till 2025 (20)
Australia Travel & Tourism Market Growth, Demand and Challenges of the Key In...IMARC Group
The Australia travel & tourism market size is projected to exhibit a growth rate (CAGR) of 2.20% during 2024-2032.
More Info:- https://www.imarcgroup.com/australia-travel-tourism-market
North America Digital Pen Market Growth, Demand and Challenges of the Key Ind...IMARC Group
The North America digital pen market size reached US$ 951.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,534.5 Million by 2032, exhibiting a growth rate (CAGR) of 11.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/north-america-digital-pen-market
Vietnam Mushroom Market Growth, Demand and Challenges of the Key Industry Pla...IMARC Group
The Vietnam mushroom market size is projected to exhibit a growth rate (CAGR) of 6.52% during 2024-2032.
More Info:- https://www.imarcgroup.com/vietnam-mushroom-market
Vietnam Lobster Market Growth, Demand and Challenges of the Key Industry Play...IMARC Group
The Vietnam Lobster market size is projected to exhibit a growth rate (CAGR) of 9.23% during 2024-2032.
More Info:- https://www.imarcgroup.com/vietnam-lobster-market
Veterinary Diagnostics Market PPT 2024: Size, Growth, Demand and Forecast til...IMARC Group
The global veterinary diagnostics market size reached US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032.
More Info:- https://www.imarcgroup.com/veterinary-diagnostics-market
Air Pollution Control Systems Market PPT 2024: Size, Growth, Demand and Forec...IMARC Group
The global air pollution control systems market size reached US$ 84.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 150.0 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/air-pollution-control-systems-market
Real Estate Software Market PPT 2024: Size, Growth, Demand and Forecast till ...IMARC Group
The global real estate software market size reached US$ 11.13 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.74 Billion by 2032, exhibiting a growth rate (CAGR) of 9.76% during 2024-2032.
More Info:- https://www.imarcgroup.com/real-estate-software-market
Azotobacter Market PPT 2024: Size, Growth, Demand and Forecast till 2032IMARC Group
The global azotobacter market size reached US$ 327.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 681.1 Million by 2032, exhibiting a growth rate (CAGR) of 8.47% during 2024-2032.
More Info:- https://www.imarcgroup.com/azotobacter-market
Europe Insurtech Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and ...IMARC Group
The Europe insurtech market size is projected to exhibit a growth rate (CAGR) of 41.20% during 2024-2032.
More Info:- https://www.imarcgroup.com/europe-insurtech-market
The global radiation oncology market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/radiation-oncology-market
The global customer journey analytics market size reached US$ 13.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 48.6 Billion by 2032, exhibiting a growth rate (CAGR) of 15.4% during 2024-2032.
More Info:- https://www.imarcgroup.com/customer-journey-analytics-market
Organ-on-chip Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opp...IMARC Group
The global organ-on-chip market size reached US$ 61.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 541.8 Million by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/organ-on-chip-market
The global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
More Info:- https://www.imarcgroup.com/disposable-syringes-market
Saudi Arabia Home Healthcare Market PPT: Growth, Outlook, Demand, Keyplayer A...IMARC Group
The Saudi Arabia home healthcare market size is projected to exhibit a growth rate (CAGR) of 7.40% during 2024-2032.
More Info:- https://www.imarcgroup.com/saudi-arabia-home-healthcare-market
Saudi Arabia Home Infusion Therapy Market PPT: Growth, Outlook, Demand, Keypl...IMARC Group
The Saudi Arabia home infusion therapy market size is projected to exhibit a growth rate (CAGR) of XX% during 2024-2032.
More Info:- https://www.imarcgroup.com/saudi-arabia-home-infusion-therapy-market
United States Hybrid Cloud Market PPT: Growth, Outlook, Demand, Keyplayer Ana...IMARC Group
The United States hybrid cloud market size is projected to exhibit a growth rate (CAGR) of 21.95% during 2024-2032.
More Info:- https://www.imarcgroup.com/united-states-hybrid-cloud-market
Saudi Arabia Electronically Commutated Fans Market PPT: Growth, Outlook, Dema...IMARC Group
The Saudi Arabia electronically commutated fans market size is projected to exhibit a growth rate (CAGR) of XX% during 2024-2032.
More Info:- https://www.imarcgroup.com/saudi-arabia-electronically-commutated-fans-market
Filling Equipment Market by Product Type, Distribution Channel, End User 2024...IMARC Group
The global filling equipment market size reached US$ 19.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.9 Billion by 2032, exhibiting a growth rate (CAGR) of 2.8% during 2024-2032.
More Info:- https://www.imarcgroup.com/filling-equipment-market
FRP Pipe Market by Product Type, Distribution Channel, End User 2024-2032IMARC Group
The global FRP pipe market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3.66% during 2024-2032.
More Info:- https://www.imarcgroup.com/frp-pipe-market
Elevator and Escalator Market by Product Type, Distribution Channel, End User...IMARC Group
The global elevator and escalator market size reached US$ 154.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 239.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.89% during 2024-2032.
More Info:- https://www.imarcgroup.com/elevator-escalator-market
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
2. About IMARC
WHO WE ARE?
• We are a leading market
research firm with
expertise in market
intelligence and business
research
• We deliver high quality,
well-knitted, meaningful
studies
• We excel at understanding
and synergizing with the
business priorities of our
partners and delivering
tailored solutions
WHAT DO WE DO?
• Market research and
business insights
• Competitive intelligence
and benchmarking
• Strategy consulting
• Consumer surveys and
feedback analysis
• Social and rural research
• Market entry strategy
• Syndicated Reports
WHAT DO WE COVER?
• Food And beverages
• Dairy and dairy products
• Agriculture and farming
• Chemicals and materials
• FMCG
• Paper and packaging
• Healthcare
• Machinery, electronics and
semiconductors
WHO DO WE SERVE?
• Collaborating with fortune
500 companies and SMEs
• Serving all major clients
from different industry
which include Chemical &
Materials, Food &
Beverages, Packaging,
Healthcare, Automotive,
Heavy Industries, Retail,
etc.
3. WhatWeDo
Cost Modeling and Cost Forecasting
Competitive Intelligence and Benchmarking
Country Entry Strategy
Consumer Survey & Feedback Reports
A good cost model supports organizations during negotiations to build strong
relationships with suppliers. Cost modelling and price forecasting services from
IMARC ensure clients make informed decisions.
At IMARC, we help customers determine a competitor’s brand image and
perception in the marketplace as compared to other key players.
IMARC team drafts and implement an optimum country entry strategy for
expanding business in the country. Our team of consultants deeply evaluates
and strategize the market opportunities for our clients and accentuate the
business in congruence with Government regulations, exports and imports
scenario, demand supply gap analysis and many more.
Consumer profiling, survey with end consumers, collection of their feedback
and deep analysis. Based on the analysis, strategic decisions to enter in a
new region, launch of new product, improvising the existing services
Market Research & Business Insights
To develop deep customer understanding, we employ a range of quantitative
and qualitative marketing research approaches along with big data
techniques that are both innovative and pragmatic
Competitive
Intelligence and
Benchmarking
Cost Modeling
and Cost
Forecasting
Country Entry
Strategy
Consumer
Survey &
Feedback
Reports
Market Research
& Business
Insights
5. According to the IMARC Group, Molecular cytogenetics includes the biomedical research of DNA mechanisms to investigate genetic
mutations and disorders. It analyzes the structural and functional organization of the chromosomes and their nucleus, genomic variations,
expression, evolution and abnormalities, particularly in medicinal and cancer-related genetics. Several techniques, such as DNA isolation,
DNA amplification, gene screens, virtual karyotyping and fluorescence in-situ hybridization (FISH), are commonly used for molecular
cytogenetics. These techniques are highly beneficial in diagnosing and treating various malignant tumors and hematological malignancies.
Request for a free sample copy of this report: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsample
Market Trends:
The growing prevalence of cancer and other genetic disorders is primarily driving the market growth. Furthermore, the widespread
adoption of targeted therapies, such as FISH and Comparative Genomic Hybridization (CGH), that help in analyzing cancer progression
stages and provide personalized treatment to the patient is further propelling the market. Additionally, several technological
advancements have led to the development of improved consumables, reagents, kits, etc., that aid in generating accurate and reliable
clinical-pathological test results, thereby driving the global market.
Report Description
6. Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along
with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on
region, product type, technology, application and end user.
• Breakup by Product Type:
• Instruments
• Consumables
• Software and Services
• Others
• Breakup by Technology:
• Comparative Genomic Hybridization
• Fluorescence in SITU Hybridization (FISH)
• Immunohistochemistry
• Karyotyping
• Others
• Breakup by Application:
• Genetic Disorders
• Oncology
• Personalized Medicine
• Others
Report Description
7. • Breakup by End User:
• Clinical and Research Laboratories
• Hospitals and Pathology Laboratories
• Pharmaceutical and Biotechnology Companies
• Others
• Breakup by Region:
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
Report Description
8. • Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories,
Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher
Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics
Incorporated.
Report Description
9. Explore Report Description: https://www.imarcgroup.com/molecular-cytogenetics-market
Browse Related Report By IMARC Group
Data Quality Tools Market: https://www.imarcgroup.com/data-quality-tools-market
Big Data Software Market: https://www.imarcgroup.com/big-data-software-market
3D Printing Market: https://www.imarcgroup.com/3d-printing-market
Cloud Security Software Market: https://www.imarcgroup.com/cloud-security-software-market
Report Description
10. Key Questions Answered in This Report:
•How has the global molecular cytogenetics market performed so far and how will it perform in the coming years?
•What has been the impact of COVID-19 on the global molecular cytogenetics market?
•What are the key regional markets?
•What is the breakup of the market based on the product type?
•What is the breakup of the market based on the technology?
•What is the breakup of the market based on the application?
•What is the breakup of the market based on the end user?
•What are the various stages in the value chain of the industry?
•What are the key driving factors and challenges in the industry?
•What is the structure of the global molecular cytogenetics market and who are the key players?
•What is the degree of competition in the industry?
Report Description
22. Team Profile
Engineers
45%
Post
Graduates
30%
Non
Engineering
Graduates
15%
Others
10%
Growing team of 150+ employees with
deep market knowledge
Over 1000 Independent Consultants from
different sectors
Talents from some of the top universities
modelling specialists with unmatched
expertise in quantitative research
Individuals with experience in specific
industries and having sound knowledge of
targeted functional areas
Commercial and non-commercial
relationships with some of the top research
institutes
Engineers and Post Graduates Account for
75% of our Team
24. “We have been working with IMARC Group for over two years now. I must say that the word impossible
doesn’t seems to appear in their dictionary,. These guys can provide data for any market in any country. I
have been given them challenging assignments to work upon and have been quite impressed with their
approach and results.” -Global
Procurement Technology Manager – Global FMCG Giant
“IMARC Group has great domain expertise and knowledge base provided all the inputs necessary for us to
define the path forward and launch our diagnostic successfully in the market where other players were always
afraid before investing.”
-Vice President Marketing – European Diagnostic Company
“We were really impressed with their research findings on the South India dairy market. The innovative idea
suggested by them have given us altogether different aspect to look at the problem. We started with them on
small project but now thinking on doing more strategic project with them.”
-National Manager (Marketing) – Indian Diary Giant
“IMARC Group helped us with the outsourcing of a major part of clinical trials to India. In the beginning we
were skeptic of this idea. But the success achieved from this strategy is driving us to outsource other verticals
of our business to low cost destinations”
- Member of Board of Managing Director – Global Pharmaceutical Giant
“Working with IMARC Group has been a great experience. They were able to provide us with a comprehensive
business report on the India wastewater treatment market. The finding from the reports are played a major
role in our business strategies and future decision making”
-Senior Vice President – Major Indian Effluent Treatment Company
Words From Client
26. Report FAQs
01
04
Do you provide market share information for a specific
country/segment?
Yes, we provide market share information and insights considering the scope. This service is
provided as a part of customization requirements.
I have a pre-defined budget. Can I buy chapters/sections of the report?
We generally do not promote the sale of separate or individual segments from within a study, as it
might fail to relay the actual meaning of the study or provide a holistic picture of the market. However,
in special cases, select chapters are provided based on the client requirement.
02
My research requirement is very specific; can I customized the report?
Yes, we provide customization of reports based on your requirements. It will be charged based on the scope
of customization. Client have free access to pre-sales analyst briefs to discuss requirement and
recommendations.
03
How do you arrive at the market numbers?
Our research methodology is a three cyclic process. It starts from information procurement from our
inhouse database, primary research and secondary sources. The second step is data collection and
analysis. The third step is data validation from industry experts, key players and other stakeholders.
05
Do you offer post sales support?
Yes, we offer post purchase analyst support for 4-6 weeks to our client in case they have any query within
the scope of study.
27. Report FAQs
08
06 Who are your client?
We have engaged 550+ clients across the globe. More than half of our client are re-engage us for
additional reports and services
07 How will I receive the report?
The report in a PDF and Excel format will be sent to you electronically at your registered email address.
Moreover, PPT and Word formats are also delivered to clients, on special requests.
09
How often does IMARC update studies?
Research studies or reports are updated once in 6 months or a year depending on the traction & need. Please
contact our sales team to inquire about a report update status.
Will I have to pay for the post-sale customization needs?
We offer our clients with a free 10% customization on the syndicated report. In case you have not availed this
service as a pre-sale facility, we request you to share the requirements with our sales team. The research team
post a feasibility will share the purview of the post-sale customization along with the price (if applicable) and
the timeline.